Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-08

Clinical Trial Update: An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

View source ↗

Summary

This document reports an observational study evaluating the efficacy and safety of risperidone long-acting injection for schizophrenia; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperidone Long Acting Injection (risperidone long-acting injectable)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Schizophrenia | Status: TERMINATED | Results posted: 2013-11-08